Stockscreener 앱 받기
43.07
7.42%
-3.45
시간 외 거래:
43.15
0.08
+0.19%
전일 마감가:
$46.52
열려 있는:
$45
하루 거래량:
1.78M
Relative Volume:
0.76
시가총액:
$3.23B
수익:
-
순이익/손실:
$-275.16M
주가수익비율:
-11.07
EPS:
-3.89
순현금흐름:
$-221.15M
1주 성능:
-9.31%
1개월 성능:
-19.16%
6개월 성능:
+35.31%
1년 성능:
-6.82%
1일 변동 폭
$43.05
$46.16
1주일 범위
$40.98
$47.88
52주 변동 폭
$28.21
$62.00
Springworks Therapeutics Inc Stock (SWTX) Company Profile
명칭
Springworks Therapeutics Inc
전화
203-883-9490
주소
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
43.07 | 3.23B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-20 | 개시 | Evercore ISI | Outperform |
| 2024-02-05 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | BofA Securities | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2020-03-19 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-04 | 개시 | H.C. Wainwright | Buy |
| 2019-10-08 | 개시 | Cowen | Outperform |
| 2019-10-08 | 개시 | Goldman | Buy |
| 2019-10-08 | 개시 | JP Morgan | Overweight |
| 2019-10-08 | 개시 | Wedbush | Outperform |
모두보기
Springworks Therapeutics Inc 주식(SWTX)의 최신 뉴스
NEOS Investment Management LLC Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Pictet Asset Management Holding SA Has $86.40 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Enters Oversold Territory (SWTX) - Nasdaq
BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Segall Bryant & Hamill LLC Acquires 58,522 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Cibc World Markets Corp Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat
SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR
Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
FDA’s new and supplemental approvals in February - BioCentury
Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga
SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat
High Growth Tech Stocks In The US Market March 2025 - Simply Wall St
How To Trade (SWTX) - Stock Traders Daily
SpringWorks Therapeutics Inc (SWTX) Q4 2024 Earnings Report Prev - GuruFocus.com
SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView
SpringWorks Therapeutics, Inc.'s (NASDAQ:SWTX) Shares Climb 26% But Its Business Is Yet to Catch Up - Simply Wall St
Victory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz - Seeking Alpha
Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Saqib Islam Sells 49,000 Shares - MarketBeat
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest? - MSN
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) COO Badreddin Edris Sells 20,000 Shares - MarketBeat
Candriam S.C.A. Reduces Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Springworks Therapeutics Inc (SWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
1.63%
자본화:
|
볼륨(24시간):